A detailed history of Two Sigma Securities, LLC transactions in Incyte Corp stock. As of the latest transaction made, Two Sigma Securities, LLC holds 11,286 shares of INCY stock, worth $836,631. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,286
Holding current value
$836,631
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $647,026 - $774,332
11,286 New
11,286 $746,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $211,842 - $265,234
3,201 New
3,201 $213,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $363,440 - $438,803
-5,505 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $348,686 - $407,975
5,505 New
5,505 $404,000
Q3 2020

Nov 16, 2020

SELL
$85.07 - $109.69 $231,645 - $298,685
-2,723 Closed
0 $0
Q2 2020

Sep 10, 2020

SELL
$74.18 - $108.93 $637,948 - $936,798
-8,600 Reduced 75.95%
2,723 $283,000
Q2 2020

Aug 14, 2020

BUY
$74.18 - $108.93 $839,940 - $1.23 Million
11,323 New
11,323 $1.18 Million
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $220,571 - $262,069
-3,029 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $222,692 - $268,672
3,029 New
3,029 $257,000
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $327,778 - $454,692
-5,157 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $301,684 - $360,680
5,157 New
5,157 $328,000
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $239,420 - $298,379
-2,559 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $279,314 - $353,832
2,559
2,559 $299,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.